These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18203414)

  • 1. [Insulinoma effectively controlled with low dose of octreotide acetate].
    Fukuoka K; Matsushita M; Murase T; Yamamori I
    Nihon Naika Gakkai Zasshi; 2007 Dec; 96(12):2786-8. PubMed ID: 18203414
    [No Abstract]   [Full Text] [Related]  

  • 2. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of benign insulinoma using octreotide LAR: a case report.
    Usukura M; Yoneda T; Oda N; Yamamoto Y; Takata H; Hasatani K; Takeda Y
    Endocr J; 2007 Feb; 54(1):95-101. PubMed ID: 17124362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin analog inhibits the growth of insulinoma cells by p27-mediated G1 cell cycle arrest.
    Aoki T; Motoi F; Sakata N; Naitoh T; Katayose Y; Egawa S; Miyazaki J; Unno M
    Pancreas; 2014 Jul; 43(5):720-9. PubMed ID: 24694834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible functional regression of insulinoma with prolonged octreotide.
    Craig CE; Gallen IW
    Postgrad Med J; 2002 Oct; 78(924):623-4. PubMed ID: 12415090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful long-term treatment with once-daily injection of low-dose octreotide in an aged patient with insulinoma.
    Katabami T; Kato H; Shirai N; Naito S; Saito N
    Endocr J; 2005 Oct; 52(5):629-34. PubMed ID: 16284444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections.
    Okamoto M; Kishimoto M; Takahashi Y; Osame K; Noto H; Yamamoto-Honda R; Kajio H; Tokuhara M; Edamoto Y; Endo H; Igari T; Kubota K; Noda M
    Endocr J; 2013; 60(8):951-7. PubMed ID: 23665775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of insulinoma by a single daily dose of octreotide in two elderly female patients.
    Kishikawa H; Okada Y; Hirose A; Tanikawa T; Kanda K; Tanaka Y
    Endocr J; 2006 Feb; 53(1):79-85. PubMed ID: 16543676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma.
    Healy ML; Dawson SJ; Murray RM; Zalcberg J; Jefford M
    Intern Med J; 2007 Jun; 37(6):406-9. PubMed ID: 17535385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinoma revealed by recurrent falls in old age.
    Beauchet O; Kressig RW; Vischer UM; de Perrot T; de Saussure P
    J Am Geriatr Soc; 2005 Mar; 53(3):552-3. PubMed ID: 15743313
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose-responsive and octreotide-sensitive insulinoma.
    Izumiyama H; Gotyo N; Fukai N; Ozawa N; Doi M; Yoshimoto T; Arii S; Hirata Y
    Intern Med; 2006; 45(8):519-24. PubMed ID: 16702744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of malignant insulin-producing pancreatic tumor treatment].
    Reutova EV; Orel NF; Besova NS; Artemova EV; Smirnova NB; Gorbunova VA
    Ter Arkh; 1999; 71(10):44-5. PubMed ID: 10612174
    [No Abstract]   [Full Text] [Related]  

  • 13. The effectiveness of administering a minimal dose of octreotide long-term prior to surgery for insulinoma: report of a case.
    Tanaka Y; Funahashi H; Imai T; Naruse T; Suzumura K; Oda Y
    Surg Today; 2000; 30(6):541-3. PubMed ID: 10883468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
    Arnold R; Neuhaus C; Trautmann ME
    Dtsch Med Wochenschr; 1992 Jul; 117(27):1067-71. PubMed ID: 1352235
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
    Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
    Dtsch Med Wochenschr; 2004 Mar; 129(13):689-92. PubMed ID: 15026965
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of insulinoma with the somatostatin analog SMS 201-995].
    Gilsanz Peral A; Gómez Balaguer M; Costa Talens P
    Med Clin (Barc); 1988 Apr; 90(15):634-5. PubMed ID: 2899658
    [No Abstract]   [Full Text] [Related]  

  • 17. Amelioration of hypoglycemia with octreotide therapy in metastatic insulinoma with positive octreotide scan.
    Wade AN; Cheng G; Teitelbaum U; Patel AA; Alavi A; Rickels MR
    Pancreas; 2011 Jan; 40(1):173-5. PubMed ID: 21160385
    [No Abstract]   [Full Text] [Related]  

  • 18. Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin).
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH; Naafs MA
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):34-40. PubMed ID: 2545062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma.
    Sulkowski U; Büchler M; Pederzoli P; Arnold R; Dinse P; Kay A; Haus U; Beger HG
    Eur J Cancer; 1999 Dec; 35(13):1805-8. PubMed ID: 10673995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of Sandostatin in the combined treatment of surgical diseases of the pancreas].
    Saenko VF; Lifshits IuZ; Kozhara SP; Usenko AIu; Andreeshchev SA; Kryzhevskiĭ VV; Olenin VV; Beliaeva OA
    Lik Sprava; 1997; (3):126-7. PubMed ID: 9377332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.